Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
31. Ganmaa D, Willett WC, Li TY, et al. Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up. International Journal of Cancer 2008; 122(9):2071–2076.
32. Inoue M, Robien K, Wang R, et al. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: The Singapore Chinese Health Study. Carcinogenesis 2008; 29(10):1967–1972.
33. Zhang M, Holman CD, Huang J-P, Xie X. Green tea and the prevention of breast cancer: A case-control study in Southeast China. Carcinogenesis 2007; 28(5):1074–1078.
34. Zhang M, Huang J, Xie X, Holman CD. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. International Journal of Cancer 2009; 124(6):1404–1408.
35. Shrubsole MJ, Lu W, Chen Z, et al. Drinking green tea modestly reduces breast cancer risk. Journal of Nutrition 2009; 139(2):310–316.
36. Kumar N, Titus-Ernstoff L, Newcomb P, et al. Tea consumption and risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2009; 18(1):341–345.
37. Ogunleye AA, Xue F, Michels KB. Green tea consumption and breast cancer risk or recurrence: A meta-analysis. Breast Cancer Research and Treatment 2010; 119(2):477–484.
38. Larsson SC, Bergkvist L, Wolk A. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Causes and Control 2009; 20(10):2039–2044.
39. Luo J, Gao Y-T, Chow WH, et al. Urinary polyphenols and breast cancer risk: Results from the Shanghai Women’s Health Study. Breast Cancer Research and Treatment 2010; 120(3):693–702.
40. Bhoo Pathy N, Peeters P, van Gils C, et al. Coffee and tea intake and risk of breast cancer. Breast Cancer Research and Treatment 2010; 121(2):461–467.
41. Dai Q, Shu XO, Li H, et al. Is green tea drinking associated with a later onset of breast cancer? Annals of Epidemiology 2010; 20(1):74–81
42. Iwasaki M, Inoue M, Sasazuki S, et al. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: A nested case-control study. Breast Cancer Research and Treatment 2010; Epub ahead of print May 4, 2010.
43. Gates MA, Tworoger SS, Hecht JL, et al. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. International Journal of Cancer 2007; 121(10):2225–2232.
44. Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE. Intake of coffee and tea and risk of ovarian cancer: A prospective cohort study. Nutrition and Cancer 2007; 58(1):22–27.
45. Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA. Tea and coffee drinking and ovarian cancer risk: Results from the Netherlands Cohort Study and a meta-analysis. British Journal of Cancer 2007; 97(9):1291–1294.
46. Baker JA, Boakye K, McCann SE, et al. Consumption of black tea or coffee and risk of ovarian cancer. International Journal of Gynecological Cancer 2007; 17(1):50–54.
47. Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers and Prevention 2008; 17(3):712–716.
48. Zhou B, Yang L, Wang L, et al. The association of tea consumption with ovarian cancer risk: A metaanalysis. American Journal of Obstetrics and Gynecology 2007; 197(6):594.e1–e6.
49. Wang L, Lee IM, Zhang SM, et al. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. American Journal of Clinical Nutrition 2009; 89(3):905–912.
50. Nagle CM, Olsen CM, Bain CJ, et al. Tea consumption and risk of ovarian cancer. Cancer Causes and Control 2010; 21(9):1485–1491.
51. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: A prospective study. American Journal of Epidemiology 2008; 167(1):71–77.
52. Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asian Pacific Journal of Clinical Nutrition 2007; 16(Suppl 1):453–457.
53. Li Q, Kakizaki M, Kuriyama S, et al. Green tea consumption and lung cancer risk: The Ohsaki study. British Journal of Cancer 2008; 99(7):1179–1184.
54. Cui Y, Morgenstern H, Greenland S, et al. Dietary flavonoid intake and lung cancer—a population-based case-control study. Cancer 2008; 112(10):2241–2248.
55. Kubík A, Zatloukal P, Tomášek L, et al. A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma 2008; 55(3):192–199.
56. Kubík A, Zatloukal P, Tomášek L, et al. Interactions between smoking and other exposures associated with lung cancer risk in women: Diet and physical activity. Neoplasma 2007; 54(1):83–88.
57. Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: A meta-analysis. Lung Cancer 2009; 65(3):274–283
58. Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proceedings from the Society of Experimental Biology and Medicine 1999; 220(4):218–224.
59. Tsao AS, Liu D, Martin J, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prevention Research 2009; 2(11):931–941.
60. Hakim IA, Harris RB, Brown S, et al. Effect of increased tea consumption on oxidative DNA damage among smokers: A randomized controlled study. Journal of Nutrition 2003; 133(10):3303S–3309S.
61. Luo H, Tang L, Tang M, et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: Modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 2006; 27(2):262–268.
62. Bettuzzi S, Brausi M, Rizzi F, et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Research 2006; 66(2):1234–1240.
63. Jatoi A, Ellison N, Burch PA, et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003; 97(6):1442–1446.
64. Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach. Urologic Oncology: Seminars and Original Investigations 2005; 23(2):108–113.
65. Hamajima N, Tajima K, Tominaga S, et al. Tea polyphenol intake and changes in serum pepsinogen levels. Japanese Journal of Cancer Research 1999; 90(2):136–143.
66. Wang LD, Zhou Q, Feng CW, et al. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho 2002; 29(Suppl 1):159–172.
Source: National Cancer Institute
